source
- Boehringer, Zealand’s obesity shot looks as good as Novo's Wegovy, but weaker than Lilly's ZepboundObesity patients taking the weight loss injection being developed by Boehringer Ingelheim lost nearly 17% of their weight after about a year and a half, the company said Tuesday. The results are mo…Endpoints · 3mo ago↗ source
- Erasca reports RAS cancer drug data after legal threat from RevolutionAfter a new drug from Revolution Medicines reignited hopes for treating pancreatic cancer, a rival compound from Erasca — which released early-stage data on Monday — could prompt a legal showdown b…Endpoints · 3mo ago↗ source
- Revolution Medicines threatens to sue Erasca over patent, efficacy claimsEarlier this month, a new cancer drug captivated patients and investors. Now the lawyers get their turn. On Monday, Erasca said it had received a legal threat from Revolution Medicines' lawyers ove…